In just over a week, Andy Cohen and Anderson Cooper will be saying, “Sayonara, sucka!” to 2025. If you were wondering if that also meant they’d be ringing in the New Year with tequila shots and more ...

In a recently released preview for the next episode of Real Housewives of Potomac, we learn something wild. As Ashley Darby is now confessing, several seasons ago, she kissed one of her co-star’s sons ...

Third Person Shooters Arc Raiders players make a plea to Embark: don't let PvP in trios poison your solo "aggression-based" matchmaking Third Person Shooters While playing Arc Raiders, Embark leads ...

Alzheimer's patients treated with the GLP-1 receptor agonist semaglutide (Rybelsus) in two phase III trials showed no significant improvement in cognitive or functional decline over 2 years compared ...

In a “Weekend Update” that featured jokes about Donald Trump and Jeffrey Epstein, a sunburned vacationer played by cast member Ben Marshall and how Netflix will jack up its prices to $50 million in ...

My wife “Amy” and I have two kids, “Mariah,” 5, and “Josh,” 8. We went over to my parents’ for Thanksgiving. They have a big house and hosted all of our extended family with a catered dinner complete ...

The culprit was caught red-handed — or in this case, black-pawed. Employees at a Virginia liquor store were startled to find more than two dozen bottles smashed on the ground and puddles of alcohol ...

Novo Nordisk announced Monday that in two closely watched studies, an oral version of semaglutide — the active ingredient in weight loss drugs — failed to help slow the progression of Alzheimer’s. The ...

Pharmaceutical giant Novo Nordisk says an oral version of semaglutide — the active ingredient in blockbuster drugs Ozempic and Wegovy has failed to slow the progression of Alzheimer’s disease in two ...

The "Full House" alum explained that she knew around the age of 15 that she "drank and partied in a way that my friends did not." Emlyn Travis is a news writer at Entertainment Weekly. She has been ...

An oral version of semaglutide, the active ingredient in blockbuster drugs Ozempic and Wegovy, failed to slow the progression of Alzheimer's disease in closely watched trials, Novo Nordisk said Monday ...